Vincristine Sulphate Injection

Form: Injection

Strength: 1 mg/10 mL (0.1 mg/mL), 2 mg/10 mL (0.2 mg/mL)

Reference Brands: Oncovin®(US)

Category: Oncology Cancer Care

Vincristine Sulphate Injection is a chemotherapy medication used in the treatment of various cancers, including leukemia, lymphoma, neuroblastoma, and Wilms tumor. As a mitotic inhibitor, vincristine works by disrupting cell division, preventing cancer cells from growing and multiplying. In the US, it is marketed under the brand name Oncovin® and is available in various strengths for intravenous administration. In the EU, it is marketed under several brand names, including Vincristine Ebewe. Ideal for B2B pharmaceutical companies looking to expand their oncology product portfolio, this injection is crucial for combination therapy in cancer management globally.